HD-OPM Archive
Topics › Aging & longevity

People with Laron syndrome (low IGF1) appear to have low cardiovascular risk

Louis Nervegna · Jun 04, 2026 · ♥ 5 reactions · 0 comments · original Facebook post
Aging & longevityHormones, women's & men's healthCardiovascular disease: the big picture
AI summary & key facts

Louis notes that people with genetically low IGF1 (Laron syndrome) have very low rates of cancer, diabetes and Alzheimer's, and a recent study suggests lower cardiovascular risk too. The linked Nature news piece describes lower blood sugar and insulin resistance in these individuals, hinting at new treatment strategies.

It is well known that people with genetically low IGF1 (Laron Syndrome) have very low rates of cancer, diabetes, and Alzheimer’s.

A recent study also demonstrates that these same people likely have decreased risk of cardiovascular disease, as well.

Link that bypasses paywall:

Science Tech UpdatesPeople with Rare Longevity Mutation may also be Protected from Cardiovascular Disease - Science Tech UpdatesPatients with growth hormone receptor deficiency, or Laron syndrome, appear to have lower than average risk factors for cardiovascular disease, according to a new study.scitechupdates.com

Quoted:

Could a rare mutation that causes dwarfism also slow ageing? People with Laron syndrome have a low risk of heart disease and a number of other age-related disorders, hinting at strategies for new treatments.

Quoted:

GHRD [Laron Syndrome] subjects displayed lower blood sugar, insulin resistance, and blood pressure compared to the control group.

They also had smaller heart dimensions and similar pulse wave velocity — a measure of stiffness in the arteries — but had lower carotid artery thickness compared to control subjects.

Despite elevated low-density lipoprotein (LDL), or “bad cholesterol,” levels, GHRD subjects showed a trend for lower carotid artery atherosclerotic plaques compared to controls (7% vs 36%).

“These findings suggest that individuals with GHRD [Laron Syndrome] have normal or improved levels of cardiovascular disease risk factors compared to their relatives,” said Longo, senior author of the new study. “Although the population tested is small, together with studies in mice and other organisms this human data provide valuable insights into the health effects of growth hormone receptor deficiency [genetically low IGF1] and suggest that drugs or dietary interventions that cause similar effects could reduce disease incidence and possibly extend longevity.”

#igf1HD #laronHD #cvdHD #valterlongoHD

Paper · Nature · 2024Could a rare mutation that causes dwarfism also slow ageing?People with Laron syndrome have a low risk of heart disease and a number of other age-related disorders, hinting at strategies for new treatments.nature.com

Research cited

← newer: Psyllium at about 10 g/day lowers LDL by roughly 13 mg/dL acolder: Laron syndrome: lifelong low IGF1 and mTOR linked to near-ab →